Serial 87250301
Live / Registered — Registered — Section 8 accepted (as of 03 Apr 2025)
What this means for you
Registered since 11 Sept 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87250301
- Registration number
- 5561718
- Mark type
- Design / logo
- Filed
- 29 Nov 2016
- Published for opposition
- 09 May 2017
- Registered
- 11 Sept 2018
- Attorney of record
- Max Moskowitz
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of diabetes
Owner
- Boehringer Ingelheim International GmbH, Ingelheim, DE
- Boehringer Ingelheim International GmbH, Ingelheim, DE
- Boehringer Ingelheim International GmbH, Ingelheim, DE
Prosecution history
- 03 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 03 Apr 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 03 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Sept 2024 — TEAS SECTION 8 RECEIVED
- 11 Sept 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Sept 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Sept 2018 — REGISTERED-PRINCIPAL REGISTER
- 10 Aug 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Aug 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Jul 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Jul 2018 — USE AMENDMENT FILED
- 27 Jul 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Jul 2018 — TEAS STATEMENT OF USE RECEIVED
- 06 Jan 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Jan 2018 — SOU EXTENSION 1 GRANTED